- ►uic.edu [PDF] KG Saag, R Emkey, TJ Schnitzer, JP Brown, F … - New England Journal of Medicine, 1998 - content.nejm.org ABSTRACT Background Osteoporosis is a common compli- cation of long-term
glucocorticoid therapy for which there is no well-proved preventive or
restorative treatment. Methods We carried out two 48-week, random- ized, ... Cited by 735 - Related articles - BL Direct - All 10 versions
- ►nih.gov [PDF] NE Lane, S Sanchez, GW Modin, HK Genant, E … - Journal of Clinical Investigation, 1998 - pubmedcentral.nih.gov Corticosteroid-induced osteoporosis is the most common secondary cause of
osteoporosis. We conducted a 12-mo, randomized clinical trial of human
parathyroid hormone 1-34 (hPTH 1-34) in postmenopausal women (mean age was ... Cited by 361 - Related articles - BL Direct - All 10 versions
JD Adachi, KG Saag, PD Delmas, UA Liberman, … - Arthritis Care & Research - interscience.wiley.com This is a 12-month extension of a previously completed 1-year trial of daily
ALN, performed to evaluate the effects of ALN over a total of 2 years in 66 men
and 142 women continuing to receive at least 7.5 mg of prednisone or ... Cited by 284 - Related articles - BL Direct - All 4 versions
S Wallach, S Cohen, DM Reid, RA Hughes, DJ … - Calcified Tissue International, 2000 - Springer 1 Hospital for Joint Diseases, New York, New York, USA 2 Metroplex Clinical
Research Center, Dallas, Texas, USA 3 Aberdeen Royal Infirmary, Aberdeen, UK 4
St Peters Hospital, Chertsey, UK 5 Nottingham City Hospital, Nottingham, UK ... Cited by 272 - Related articles - BL Direct - All 4 versions
R Eastell, DM Reid, J Compston, C Cooper, I … - Journal of Internal Medicine, 1998 - interscience.wiley.com Abstract. Eastell R, Reid DM, Compston J, Cooper C, Fogelman I, Francis RM,
Hosking DJ, Purdie DW, Ralston SH, Reeve J, Russell RGG, Stevenson JC, Torgerson
DJ (University of Sheffield Medical School, Sheffield; University of ... Cited by 262 - Related articles - BL Direct - All 5 versions
- ►adisonline.com [PDF] JD Adachi, WP Olszynski, DA Hanley, AB … - Seminars in arthritis and rheumatism, 2000 - Elsevier Despite our lack of understanding about the biological mechanisms leading to
corticosteroid-induced bone loss, effective therapy has been developed.
Bisphosphonate therapy is beneficial in both the prevention and treatment ... Cited by 224 - Related articles - BL Direct - All 21 versions
- ►eje-online.org [PDF] IR Reid - European Journal of Endocrinology, 1997 - EFES Glucocorticoids are potent osteopenic agents, producing negative calcium and
bone balance via actions at many sites. The most significant adverse effects of
glucocorticoid drugs on the skeleton are probably a direct inhibition of ... Cited by 171 - Related articles - BL Direct - All 9 versions
- ►bmj.com EM Scott, I Gaywood, BB Scott - British Medical Journal, 2000 - gut.bmj.com Osteoporotic fractures are a major public health problem. It has been estimated
that in the USA the remaining lifetime fracture risk at the age of 50 years is
40% for white women and 13% for white men, 1 the major fracture sites being ... Cited by 159 - Related articles - BL Direct - All 9 versions
- ►nutrition.org MT Cantorna, C Munsick, C Bemiss, BD … - Journal of Nutrition, 2000 - Am Soc Nutrition Anecdotal data suggest that the amount of vitamin D available in the environment
either from sunshine exposure or diet may be an important factor affecting the
development of inflammatory bowel disease (IBD) in humans. We tested the ... Cited by 142 - Related articles - BL Direct - All 6 versions
- ►cnfindpark.cn MT Cantorna, Y Zhu, M Froicu, A Wittke - American Journal of Clinical Nutrition, 2004 - ajcn.cnfindpark.cn Vitamin D is an important immune system regulator. The active form of vitamin D,
1,25-dihydroxyvitamin D 3 [1,25(OH) 2 D 3 ], has been shown to inhibit the
development of autoimmune diseases, including inflammatory bowel disease ... Cited by 137 - Related articles - All 7 versions
